Goodwin filed an amicus brief on behalf of its client, Teva Pharmaceuticals USA, Inc., in this precedent-setting personal jurisdiction case. Goodwin lawyers argued (and the Federal Circuit ultimately held) that specific personal jurisdiction exists in patent-litigation cases under the Hatch-Waxman Act in any jurisdiction in which an ANDA filer will engage in infringing sales upon receiving FDA approval.

Leave a reply